New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
17:04 EDTSUPN, UTHRSupernus receives $2M milestone payment for launch of Orenitram
Supernus Pharmaceuticals (SUPN) announced that United Therapeutics Corporation (UTHR) has paid Supernus a $2M milestone payment under United Therapeutics' license agreement with Supernus. This payment was due upon the launch of Orenitram Extended-Release Tablets for the treatment of pulmonary arterial hypertension, in the United States. Orenitram utilizes a Supernus patented technology platform. In addition to the launch milestone, Supernus will receive royalties on net sales of Orenitram, and may become entitled to additional milestone payments.
News For SUPN;UTHR From The Last 14 Days
Check below for free stories on SUPN;UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
14:00 EDTSUPNFBR Capital to hold a conference
Healthcare Conference to be held in Boston on September 3.
August 29, 2014
16:21 EDTUTHROn The Fly: Closing Wrap
Subscribe for More Information
13:05 EDTUTHRUnited Therapeutics price target raised to $141 from $133 at Wedbush
Subscribe for More Information
12:53 EDTUTHRCourt ruling in Remodulin patent case favors United Therapeutics
Subscribe for More Information
12:49 EDTUTHRStocks with increasing volume options volume
Stocks with increasing volume options volume: OXY HD RSH UTHR IRF TTWO CONN
12:18 EDTUTHROn The Fly: Midday Wrap
Subscribe for More Information
11:07 EDTUTHRHigh option volume stocks
Subscribe for More Information
10:51 EDTUTHRUnited Therapeutics jumps after court rules generic will infringe
United Therapeutics (UTHR) alleged patent infringement against Sandoz, a unit of Novartis (NVS), related to the latter's filing for approval of a generic version of United Therapeutics' remodulin drug. A New Jersey court ruled today that Sandoz's proposed ANDA product will infringe the claims of UTC's '117 patent, according to a court filing. Following the court ruling, shares of United Therapeutics are up 15% to $105.39 in morning trading.
August 21, 2014
07:38 EDTSUPNSupernus announces paragraph IV Abbreviated NDA filing for Trokendi XR
Subscribe for More Information
August 18, 2014
11:41 EDTUTHRCubist rises after report sparks takeover interest speculation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use